DE69520022T2 - Steroid-Verbindungen mit einer 17-Spiromethylen-Lakton- oder Lactol-Gruppe - Google Patents

Steroid-Verbindungen mit einer 17-Spiromethylen-Lakton- oder Lactol-Gruppe

Info

Publication number
DE69520022T2
DE69520022T2 DE69520022T DE69520022T DE69520022T2 DE 69520022 T2 DE69520022 T2 DE 69520022T2 DE 69520022 T DE69520022 T DE 69520022T DE 69520022 T DE69520022 T DE 69520022T DE 69520022 T2 DE69520022 T2 DE 69520022T2
Authority
DE
Germany
Prior art keywords
hydroxy
lactone
alkyl
norchola
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69520022T
Other languages
German (de)
English (en)
Other versions
DE69520022D1 (de
Inventor
Johannes Antonius Maria Hamersma
Jaap Van Der Louw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of DE69520022D1 publication Critical patent/DE69520022D1/de
Application granted granted Critical
Publication of DE69520022T2 publication Critical patent/DE69520022T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0092—Alkenyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69520022T 1994-10-27 1995-10-24 Steroid-Verbindungen mit einer 17-Spiromethylen-Lakton- oder Lactol-Gruppe Expired - Fee Related DE69520022T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94203117 1994-10-27

Publications (2)

Publication Number Publication Date
DE69520022D1 DE69520022D1 (de) 2001-03-08
DE69520022T2 true DE69520022T2 (de) 2001-06-13

Family

ID=8217314

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69520022T Expired - Fee Related DE69520022T2 (de) 1994-10-27 1995-10-24 Steroid-Verbindungen mit einer 17-Spiromethylen-Lakton- oder Lactol-Gruppe

Country Status (26)

Country Link
US (1) US5741786A (https=)
EP (1) EP0709394B1 (https=)
JP (1) JPH08225590A (https=)
KR (1) KR100402636B1 (https=)
CN (1) CN1052237C (https=)
AT (1) ATE199015T1 (https=)
AU (1) AU689642B2 (https=)
BR (1) BR9504576A (https=)
CA (1) CA2161490A1 (https=)
CZ (1) CZ287346B6 (https=)
DE (1) DE69520022T2 (https=)
DK (1) DK0709394T3 (https=)
ES (1) ES2157290T3 (https=)
FI (1) FI113542B (https=)
GR (1) GR3035713T3 (https=)
HU (1) HU221192B1 (https=)
IL (1) IL115659A (https=)
NO (1) NO305252B1 (https=)
NZ (1) NZ280325A (https=)
PL (1) PL187083B1 (https=)
PT (1) PT709394E (https=)
RU (1) RU2168516C2 (https=)
SG (1) SG33569A1 (https=)
TR (1) TR199501327A2 (https=)
TW (1) TW339337B (https=)
ZA (1) ZA958963B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
DE19651000A1 (de) * 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US6043235A (en) * 1999-07-21 2000-03-28 Research Triangle Institute 11β-aryl-17, 17-spirothiolane-substituted steroids
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
WO2021198467A1 (en) * 2020-04-03 2021-10-07 Rockwool International A/S Method of draining water

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2875199A (en) * 1958-04-22 1959-02-24 Searle & Co Lactones of 17-carboxyalkylated estra-1, 3, 5(10)-triene-3, 17-diols and 3-ethers
US3547912A (en) * 1968-07-29 1970-12-15 American Home Prod Derivatives of 2h-pyran-3(6h)-ones and preparation thereof
US3764596A (en) * 1971-06-22 1973-10-09 Sandoz Ag 17-dihydrofuranyl-substituted steroids
DE3306554A1 (de) * 1983-02-22 1984-08-23 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von 3-((delta)(pfeil hoch)4(pfeil hoch)-3-ketosteroid-17(alpha)-yl)-propionsaeurelactonen
DE3347510A1 (de) * 1983-12-27 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von 3-oxo-17(alpha)-pregna-4,6-dien-21,17-carbolactonen
FR2596395B1 (fr) * 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
ES2053714T3 (es) * 1987-12-12 1994-08-01 Akzo Nv Proceso para la preparacion de 11-arilesteroides.
FR2688004A1 (fr) * 1992-02-27 1993-09-03 Roussel Uclaf Nouveaux sterouides comportant en position 17 un radical methylene lactone, leur procede et des intermediaires de preparation, leur application comme medicaments.

Also Published As

Publication number Publication date
PT709394E (pt) 2001-06-29
CA2161490A1 (en) 1996-04-28
NO305252B1 (no) 1999-04-26
ATE199015T1 (de) 2001-02-15
GR3035713T3 (en) 2001-07-31
EP0709394B1 (en) 2001-01-31
KR100402636B1 (ko) 2004-02-05
IL115659A (en) 2000-06-01
HU221192B1 (en) 2002-08-28
DE69520022D1 (de) 2001-03-08
PL187083B1 (pl) 2004-05-31
RU2168516C2 (ru) 2001-06-10
KR960014152A (ko) 1996-05-22
FI955108L (fi) 1996-04-28
SG33569A1 (en) 1996-10-18
EP0709394A2 (en) 1996-05-01
ZA958963B (en) 1996-05-23
NO954293D0 (no) 1995-10-26
IL115659A0 (en) 1996-01-19
PL311135A1 (en) 1996-04-29
NZ280325A (en) 1997-03-24
EP0709394A3 (en) 1996-09-18
AU3445795A (en) 1996-05-09
TR199501327A3 (https=) 1996-06-21
AU689642B2 (en) 1998-04-02
BR9504576A (pt) 1997-05-20
US5741786A (en) 1998-04-21
CN1131158A (zh) 1996-09-18
TR199501327A2 (tr) 1996-06-21
FI955108A0 (fi) 1995-10-26
HU9503068D0 (en) 1995-12-28
HUT73482A (en) 1996-08-28
CZ275595A3 (en) 1996-05-15
JPH08225590A (ja) 1996-09-03
FI113542B (fi) 2004-05-14
DK0709394T3 (da) 2001-06-18
ES2157290T3 (es) 2001-08-16
CZ287346B6 (en) 2000-10-11
CN1052237C (zh) 2000-05-10
TW339337B (en) 1998-09-01
NO954293L (no) 1996-04-29

Similar Documents

Publication Publication Date Title
DE69326805T2 (de) 17-Spiromethylensteroide
DE68927861T2 (de) 11 beta-substituierte progesteron-analoge
AT396109B (de) Verfahren zur herstellung neuer 3-keto-delta 4,9,19-norsteroid-derivate
EP0254670B1 (de) 11beta-(4-Isopropenylphenyl)-estra-4,9-diene, deren Herstellung und diese enthaltende pharmazeutische Präparate
DE69520022T2 (de) Steroid-Verbindungen mit einer 17-Spiromethylen-Lakton- oder Lactol-Gruppe
DE69205405T2 (de) 17-Spirofuran-3'-Yliden Steroide.
DE3878198T2 (de) 11-arylsteroid-derivate.
EP0404283B1 (de) 11-Beta-aryl-4-estrene, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
EP0360369B1 (de) 11Beta-phenyl-14betaH-steroide
DE3723788A1 (de) 11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE2805490A1 (de) In 11beta-stellung substituierte steroide der oestranreihe
DE4042004A1 (de) 14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene
EP0104387A1 (de) 11-Beta-Aryl-17-alpha-alkinyl-17-beta-hydroxy-4,9(10)-estradien-3-on-Derivate, deren Herstellung und diese enthaltende pharmazeutische Präparate
EP0799238B1 (de) 14alpha,17alpha-c2-überbrückte 19-nor-progesteronderivate
DE60000826T2 (de) 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene
EP0034114B1 (de) 3-Desoxy-delta-15-Steroide, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
DE1618871B2 (de) Verfahren zur herstellung eines steroidketonderivates
DE2018055A1 (de) Neue Steroide und Verfahren zu ihrer Herstellung
DE2018087A1 (de) Verfahren zur Herstellung von 17 alpha - Propadienylsteroiden
WO1995027725A1 (de) 11β,19-ÜBERBRÜCKTE 13α-ALKYLSTEROIDE
WO1995011915A1 (de) 10,11β-C2-ÜBERBRÜCKTE STEROIDE
DE19535851A1 (de) 18-Norsteroide mit gestagener Wirkung

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee